52328 Federal Register / Vol. 76, No. 162 / Monday, August 22, 2011 / Notices 

Dated: August 17, 2011. 

Robert E. Feldman, 

Executive Secretary. 

[FR Doc. 2011–21324 Filed 8–19–11; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The application also will be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than September 16, 

2011. 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. American State Bancshares, Inc., 

Great Bend, Kansas; to acquire 100 

percent of the voting shares of Rose Hill 

Bancorp, Inc., and thereby indirectly 

acquire voting shares of Rose Hill Bank, 

both in Rose Hill, Kansas. 

Board of Governors of the Federal Reserve 

System, August 17, 2011. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2011–21339 Filed 8–19–11; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[CFDA 93.019] 

Single Source Cooperative Agreement 

Award for the Gorgas Memorial 

Institute of Health Studies 

AGENCY: Office of Policy and Planning 

(OPP), Office of the Assistant Secretary 

for Preparedness and Response (ASPR), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: In FY2011, HHS/ASPR/OPP 

plans to provide a Single Source 

Cooperative Agreement Award to GMI 

to strengthen Panama’s laboratory 

diagnostic capacity for emerging 

infectious disease threats including 

select bio-terrorism agents and novel 

influenza viruses. The amount of Single 

Source award is $200,000. The project 

period is: September 30, 2011 to 

September 29, 2012. 

SUPPLEMENTARY INFORMATION: 

ASPR will exercise sole 

administrative oversight of this 

cooperative agreement. ASPR will also 

collaborate with HHS–Centers for 

Disease Control and Prevention (CDC) to 

coordinate the provision of technical 

expertise needed for GMI to become a 

member of the LRN. GMI will then 

implement critical laboratory diagnostic 

capacities, including personnel training 

and infrastructure improvement to meet 

the standards to become an 

international affiliate of LRN. 

This collaboration seeks to expand the 

laboratory diagnostic capacity of 

Panama and the Central American 

Region as GMI is a national and regional 

reference laboratory for several 

infectious diseases. The work will be 

performed to support the 

implementation of the World Health 

Organization (WHO)’s International 

Health Regulations [IHR (2005)] in 

Panama and in the context of Article 44 

of the IHR (2005), which directs State 

Parties to collaborate with each other to 

detect, assess, and respond to events, 

and to develop, strengthen, and 

maintain core capacities for disease 

surveillance and response to public 

health emergencies. 

Single Source Justification 

GMI is a public health institution 

within the Ministry of Health of Panama 

which provides research, public health 

services and advice on public health 

policy development. It was created in 

1928 and was primarily funded by the 

United State Government (USG) until 

1991. GMI was named after General 

William Crawford Gorgas, the U.S. 

Army physician who managed control 

efforts of yellow fever, malaria and other 

diseases during the building of the 

Panama Canal. GMI contributes to 

improve the health of the population of 

Panama and Central America by acting 

as a national reference public health 

laboratory to diagnose diseases like 

yellow fever, malaria, measles, 

tuberculosis, arbovirus febrile illness, 

viral encephalitidies, influenza, dengue, 

hantavirus cardiopulmonary syndrome, 

and all endemic viral and bacterial 

diseases. Most recently GMI became a 

World Bank-Pan-American Health 

Organization reference laboratory for 

human immunodeficiency virus (HIV) 

for the Central American region. GMI 

has well-established laboratories of 

virology, parasitology, immunology, 

genomics, entomology and food and 

water chemistry. GMI also has 

departments of epidemiology and 

biostatistics, chronic disease studies, 

health policy, and health and human 

reproduction studies. This 

infrastructure positions GMI as a key 

institution in Panama’s national 

research and public health systems. 

In 2006, GMI signed a Memorandum 

of Understanding (MOU) with HHS to 

identify joint opportunities to improve 

preparedness for and response to 

infectious diseases, placing specific 

emphasis on influenza and other 

respiratory diseases. To further the goals 

of the MOU, GMI was awarded two 

cooperative agreements by HHS–ASPR 

to increase its virology diagnostic 

capacity and strengthen the surveillance 

of influenza virus in Panama and 

Central American, and to develop a 

Regional Health Care Training Center 

(RHCTC) for health care workers of the 

Central American and Caribbean region. 

These cooperative agreements helped to 

establish the first country-wide sentinel 

influenza surveillance network, and a 

BSL–3 laboratory virology suite that was 

built and inaugurated in 2010. In 

addition, complementary 

epidemiological and laboratory training 

efforts took place at the RHCTC 

benefitting more than 5,000 

professionals from Panama, Belize, 

Costa Rica, El Salvador, Guatemala, 

Honduras and Nicaragua, and 

Dominican Republic. Based on the 

capacities developed under these 

projects, the GMI was designated as 

Panama’s ‘‘National Influenza Center’’ 

by the World Health Organization 

(WHO). 

By supporting GMI to become a 

qualified member of the LRN, the USG 

will increase its international network 

of laboratories that are fully equipped to 

detect, assess and report the outbreak of 

emerging infectious diseases including 


jlentini on DSK4TPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 162 / Monday, August 22, 2011 / Notices 52329 

novel influenza viruses and biological 

agents that pose a threat to global public 

health. Through this international 

collaboration ASPR will capitalize on 

GMI’s influential position as an 

important regional partner on disease 

surveillance efforts and public health 

emergency preparedness. This new 

cooperative agreement will help to 

further strengthen laboratory diagnostic 

capacity in Panama and other countries 

in the region. GMI’s strong collaborative 

relationships with neighboring 

governments, as well as its training 

capabilities, and laboratory 

infrastructure will be critical for the 

viability of this partnership. In addition, 

this collaboration will support overall 

HHS efforts to continue building 

capacity abroad with the ultimate intent 

of detecting, stopping, slowing or 

otherwise limiting the threat or actual 

spread of bio-terrorism agents or a 

pandemic to the United States, thereby 

enhancing the health security of the 

American population. 

ADDITIONAL INFORMATION: The agency 

program contact is Dr. Maria Julia 

Marinissen, who can be contacted at 

202–205–4214 or 

Maria.Marinissen@hhs.gov. 

Statutory Authority: Sections 301, 307, 

1701 and 2811 of the Public Health Service 

Act, 42 U.S.C. 241, 242l, 300u, 300hh–10. 

Dated: August 15, 2011. 

Nicole Lurie, 

Assistant Secretary for Preparedness and 

Response. 

[FR Doc. 2011–21294 Filed 8–19–11; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health: Notice of Charter 

Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

Advisory Board on Radiation and 

Worker Health, Department of Health 

and Human Services, has been renewed 

for a 2-year period through August 3, 

2013. 

For information, contact Mr. 

Theodore Katz, Designated Federal 

Officer, Advisory Board on Radiation 

and Worker Health, Department of 

Health and Human Services, 1600 

Clifton Road, M/S E20, Atlanta, Georgia 

30341, telephone 404/498–2533, or fax 

404/498–2570. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: August 12, 2011. 

Elizabeth Millington, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2011–21413 Filed 8–19–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–11–11KA] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Catina Conner, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Use of Evidence-Based Practices for 

Comprehensive Cancer Control—New— 

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

There have been increasing calls in 

the fields of public health generally and 

cancer control specifically for the 

dissemination, adoption, and 

implementation of evidence-based 

practices (EBPs). EBPs are public health 

practices (interventions, programs, 

strategies, policies, procedures, 

processes, and/or activities) that have 

been tested or evaluated and shown to 

be effective. However, while the 

development, review, and compilation 

of EBPs has steadily increased over 

time, there is concern that the adoption 

and implementation of those practices, 

including among cancer control 

planners and practitioners, has not kept 

pace. Given the gap between the 

development of EBPs and their use, 

public health and cancer control 

organizations need to place greater 

emphasis on the promotion and 

dissemination of these practices among 

those who can use them to improve 

population health. 

While efforts to promote cancer 

control EBPs have increased, questions 

remain whether these efforts will result 

in widespread adoption and 

implementation of EBPs in the context 

of comprehensive cancer control (CCC) 

in the states, Tribes, and U.S. 

Associated Pacific Island Jurisdictions 

and territories. National Comprehensive 

Cancer Control Program (NCCCP) 

grantees may face a number of 

challenges to incorporating EBPs into 

CCC efforts in their jurisdictions. In 

order to address these barriers 

effectively and better promote the use of 

EBPs for cancer control, CDC would like 

to understand (1) how evidence-based 

approaches are currently being used to 

develop CCC plans; (2) how CCC 

programs identify EBPs; (3) what EBPs 

have been adopted by CCC programs; 

and (4) what challenges and unintended 

consequences have been encountered in 

their implementation. 

CDC plans to conduct a new, one-time 

study to examine CCC planners’ use of 

scientific and practice-based 

information to inform development of 

their CCC plans. Information collection 

will consist of two Web-based surveys 

involving key CCC stakeholders in the 

NCCCP-funded states, Tribes, and U.S. 

Associated Pacific Island Jurisdictions 

and territories. Respondents for the first 

survey will be Directors of the 66 

NCCCP-funded programs, who will also 

have the opportunity to participate in a 

follow-up telephone call. Respondents 

for the second survey will be key 


jlentini on DSK4TPTVN1PROD with NOTICES